EP3261629A4 - Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral - Google Patents

Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral Download PDF

Info

Publication number: EP3261629A4
Authority: EP; European Patent Office
Prior art keywords: flavonoid; terpene; mineral; compositions; combinations
Prior art date: 2015-02-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP16756533.2A

Other languages

German (de)

French (fr)

Other versions

EP3261629A1 (en

Inventor

Jonathan Michael COOPER

Kurt Aron LEVY

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Canopy Growth Corp

Original Assignee

Ebbu LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-02-27

Filing date

2016-02-26

Publication date

2018-12-05

2016-02-26 Application filed by Ebbu LLC filed Critical Ebbu LLC

2016-02-26 Priority claimed from PCT/US2016/019979 external-priority patent/WO2016138505A1/en

2018-01-03 Publication of EP3261629A1 publication Critical patent/EP3261629A1/en

2018-12-05 Publication of EP3261629A4 publication Critical patent/EP3261629A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP16756533.2A 2015-02-27 2016-02-26 Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral Withdrawn EP3261629A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562126365P	2015-02-27	2015-02-27
PCT/US2016/019979 WO2016138505A1 (en)	2015-02-27	2016-02-26	Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral

Publications (2)

Publication Number	Publication Date
EP3261629A1 EP3261629A1 (en)	2018-01-03
EP3261629A4 true EP3261629A4 (en)	2018-12-05

Family

ID=60400327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP16756533.2A Withdrawn EP3261629A4 (en)	2015-02-27	2016-02-26	Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral

Country Status (2)

Country	Link
EP (1)	EP3261629A4 (en)
CN (1)	CN107405314A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106591359B (en) *	2017-02-13	2019-10-25	黑龙江省科学院大庆分院	A kind of construction method of hemp THCA synthase gene RNAi carrier
CA3134764A1 (en) *	2019-04-24	2020-10-29	Eric Hsu	Compositions and methods for use of cannabinoids for neuroprotection
JP2022532116A (en)	2019-05-06	2022-07-13	ザユニバーシティオブブリティッシュコロンビア	Antibiotic cannabinoid-terpene preparation
US11187056B1 (en)	2020-05-11	2021-11-30	Schlumberger Technology Corporation	Rotating control device system
CN112807301A (en) *	2020-12-30	2021-05-18	福建省中科生物股份有限公司	Application of Cannabicol extracted from hemp plant in preparing antitumor drug
CN114586785B (en) *	2022-03-11	2023-05-05	天津市农业科学院	Application of dexcarvone as insect pathogenic nematode attractant

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2495118A (en) *	2011-09-29	2013-04-03	Gw Pharma Ltd	A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
WO2014100231A1 (en) *	2012-12-18	2014-06-26	Kotzker Consulting Llc	Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
US20140271940A1 (en) *	2013-03-14	2014-09-18	Sc Laboratories, Inc.	Bioactive concentrates and uses thereof
WO2015068052A2 (en) *	2013-10-31	2015-05-14	Full Spectrum Laboratories, Ltd.	Terpene and cannabinoid formulations
WO2015200049A1 (en) *	2014-06-26	2015-12-30	Island Breeze Systems Ca, Llc	Mdi related products and methods of use
WO2016109624A1 (en) *	2014-12-30	2016-07-07	University Of Houston System	Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0329635D0 (en) *	2003-12-23	2004-01-28	Johnson Matthey Plc	Process for purifying trans-tetrahydrocannabinol
GB2478595B (en) *	2010-03-12	2018-04-04	Gw Pharma Ltd	Phytocannabinoids in the treatment of glioma

2016
- 2016-02-26 CN CN201680015774.9A patent/CN107405314A/en active Pending
- 2016-02-26 EP EP16756533.2A patent/EP3261629A4/en not_active Withdrawn

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2495118A (en) *	2011-09-29	2013-04-03	Gw Pharma Ltd	A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
WO2014100231A1 (en) *	2012-12-18	2014-06-26	Kotzker Consulting Llc	Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
US20140271940A1 (en) *	2013-03-14	2014-09-18	Sc Laboratories, Inc.	Bioactive concentrates and uses thereof
WO2015068052A2 (en) *	2013-10-31	2015-05-14	Full Spectrum Laboratories, Ltd.	Terpene and cannabinoid formulations
WO2015200049A1 (en) *	2014-06-26	2015-12-30	Island Breeze Systems Ca, Llc	Mdi related products and methods of use
WO2016109624A1 (en) *	2014-12-30	2016-07-07	University Of Houston System	Pharmaceutical compositions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ETHAN B RUSSO: "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects : Phytocannabinoid-terpenoid entourage effects", BRITISH JOURNAL OF PHARMACOLOGY, vol. 163, no. 7, 12 July 2011 (2011-07-12), UK, pages 1344 - 1364, XP055420723, ISSN: 0007-1188, DOI: 10.1111/j.1476-5381.2011.01238.x *
SAMIR A. ROSS ET AL: "The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa", JOURNAL OF NATURAL PRODUCTS., vol. 59, no. 1, 1 January 1996 (1996-01-01), US, pages 49 - 51, XP055381204, ISSN: 0163-3864, DOI: 10.1021/np960004a *
See also references of WO2016138505A1 *

Also Published As

Publication number	Publication date
EP3261629A1 (en)	2018-01-03
CN107405314A (en)	2017-11-28

Publication	Publication Date	Title
IL254025A0 (en)	2017-10-31	Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
EP3380096A4 (en)	2019-10-23	Cannabis oil compositions and methods for preparation thereof
EP3493799A4 (en)	2020-04-01	Cannabis
EP3253727A4 (en)	2018-08-08	Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
EP3503875A4 (en)	2020-06-24	Water soluble compositions comprising purified cannabinoids
EP3302033A4 (en)	2018-10-31	Cannabis plants having modified expression of thca synthase
EP3478308A4 (en)	2020-07-22	Cannabis compositions and methods
EP3346997A4 (en)	2019-05-15	Bioorthogonal compositions
EP3297455A4 (en)	2019-02-20	Glycoside compositions
EP3229789A4 (en)	2018-08-08	Microencapsulated cannabinoid compositions
EP3291807A4 (en)	2018-05-16	Hydrogenation of cannabis oil
EP3240555A4 (en)	2018-12-05	Multi-supplement compositions
EP3295635A4 (en)	2018-05-16	LOW PAPR WAVEFORM FOR mmW
EP3371282A4 (en)	2019-06-12	Friction-reducing compositions formulated with highly concentrated brine
EP3528784A4 (en)	2020-06-10	Suppositories comprising cannabinoids
EP3133939A4 (en)	2018-03-28	Topical compositions and methods for reducing oxidative stress
EP3288553A4 (en)	2018-12-26	Combinations of cannabinoids and n-acylethanolamines
EP3493798A4 (en)	2020-05-06	Cannabis
EP3261629A4 (en)	2018-12-05	Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
EP3223628A4 (en)	2018-07-04	Glycoside compositions
AU2016291708B2 (en)	2020-12-24	Plinabulin compositions
EP3337648A4 (en)	2019-05-01	Low profile chainsaw
EP3279293A4 (en)	2018-08-08	Lubricant composition
EP3223609A4 (en)	2018-07-18	Novel diterpene glycosides, compositions and purification methods
EP3589129A4 (en)	2020-11-25	Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes

Legal Events

Date	Code	Title	Description
2017-09-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2017-12-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2017-12-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-01-03	17P	Request for examination filed	Effective date: 20170825
2018-01-03	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2018-01-03	AX	Request for extension of the european patent	Extension state: BA ME
2018-06-06	DAV	Request for validation of the european patent (deleted)
2018-06-06	DAX	Request for extension of the european patent (deleted)
2018-10-19	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1248587 Country of ref document: HK
2018-12-05	A4	Supplementary search report drawn up and despatched	Effective date: 20181106
2018-12-05	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/05 20060101AFI20181029BHEP Ipc: A61K 31/352 20060101ALI20181029BHEP Ipc: A61K 31/122 20060101ALI20181029BHEP Ipc: A61K 31/353 20060101ALI20181029BHEP Ipc: A61K 36/185 20060101ALI20181029BHEP
2019-01-09	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: EBBU INC.
2019-07-24	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: CANOPY GROWTH CORPORATION
2021-04-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2021-05-05	17Q	First examination report despatched	Effective date: 20210331
2021-08-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-09-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2023-11-01	18D	Application deemed to be withdrawn	Effective date: 20230607
2024-09-20	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1248587 Country of ref document: HK